 | • レポートコード：D0804-16497 • 出版社/出版日：GlobalInfoResearch / 2020年8月3日 ※2025年版があります。お問い合わせください。 • レポート形態：英語、PDF、103ページ • 納品方法：Eメール • 産業分類：医薬品・治療 |
| Single User | ￥504,600 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥756,900 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,009,200 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、診断用放射性医薬品の世界市場を広く調査・分析し、今後の市場展望をまとめております。診断用放射性医薬品の種類別市場規模（Tc-99m、F-18、その他）、用途別市場規模（腫瘍、循環器、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Bracco Imaging、China Isotope & Radiation、Nordion、Bayer、GE Healthcare、Curium Pharmaceuticals、Eli Lilly、Lantheus、Triad Isotopes、Jubilant Pharma、Novartis、Navidea、SIEMENS、Dongcheng ・地域別グローバル市場分析 2015年-2020年 ・診断用放射性医薬品の北米市場（アメリカ、カナダ、メキシコ） ・診断用放射性医薬品のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・診断用放射性医薬品のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・診断用放射性医薬品の南米市場（ブラジル、アルゼンチン） ・診断用放射性医薬品の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：Tc-99m、F-18、その他 ・用途別分析：腫瘍、循環器、その他 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The global Radiopharmaceuticals for Diagnostic market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Radiopharmaceuticals for Diagnostic market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Radiopharmaceuticals for Diagnostic market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Radiopharmaceuticals for Diagnostic market has been segmented into:
Tc-99m
F-18
Other
By Application, Radiopharmaceuticals for Diagnostic has been segmented into:
Oncology
Cardiology
Other
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Radiopharmaceuticals for Diagnostic market presented in the report. This section sheds light on the sales growth of different regional and country-level Radiopharmaceuticals for Diagnostic markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Radiopharmaceuticals for Diagnostic market.
The report offers in-depth assessment of the growth and other aspects of the Radiopharmaceuticals for Diagnostic market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Radiopharmaceuticals for Diagnostic Market Share Analysis
Radiopharmaceuticals for Diagnostic competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Radiopharmaceuticals for Diagnostic sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Radiopharmaceuticals for Diagnostic sales, revenue and market share for each player covered in this report.
The major players covered in Radiopharmaceuticals for Diagnostic are:
Bracco Imaging
China Isotope & Radiation
Nordion
Bayer
GE Healthcare
Curium Pharmaceuticals
Eli Lilly
Lantheus
Triad Isotopes
Jubilant Pharma
Novartis
Navidea
SIEMENS
Dongcheng
Table of Contents
1 Radiopharmaceuticals for Diagnostic Market Overview
1.1 Product Overview and Scope of Radiopharmaceuticals for Diagnostic
1.2 Classification of Radiopharmaceuticals for Diagnostic by Type
1.2.1 Global Radiopharmaceuticals for Diagnostic Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Radiopharmaceuticals for Diagnostic Revenue Market Share by Type in 2019
1.2.3 Tc-99m
1.2.4 F-18
1.2.5 Other
1.3 Global Radiopharmaceuticals for Diagnostic Market by Application
1.3.1 Overview: Global Radiopharmaceuticals for Diagnostic Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Oncology
1.3.3 Cardiology
1.3.4 Other
1.4 Global Radiopharmaceuticals for Diagnostic Market by Regions
1.4.1 Global Radiopharmaceuticals for Diagnostic Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Radiopharmaceuticals for Diagnostic (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Radiopharmaceuticals for Diagnostic Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Radiopharmaceuticals for Diagnostic Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Radiopharmaceuticals for Diagnostic Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Radiopharmaceuticals for Diagnostic Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Radiopharmaceuticals for Diagnostic Status and Prospect (2015-2025)
2 Company Profiles
2.1 Bracco Imaging
2.1.1 Bracco Imaging Details
2.1.2 Bracco Imaging Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Bracco Imaging SWOT Analysis
2.1.4 Bracco Imaging Product and Services
2.1.5 Bracco Imaging Radiopharmaceuticals for Diagnostic Revenue, Gross Margin and Market Share (2018-2019)
2.2 China Isotope & Radiation
2.2.1 China Isotope & Radiation Details
2.2.2 China Isotope & Radiation Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 China Isotope & Radiation SWOT Analysis
2.2.4 China Isotope & Radiation Product and Services
2.2.5 China Isotope & Radiation Radiopharmaceuticals for Diagnostic Revenue, Gross Margin and Market Share (2018-2019)
2.3 Nordion
2.3.1 Nordion Details
2.3.2 Nordion Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Nordion SWOT Analysis
2.3.4 Nordion Product and Services
2.3.5 Nordion Radiopharmaceuticals for Diagnostic Revenue, Gross Margin and Market Share (2018-2019)
2.4 Bayer
2.4.1 Bayer Details
2.4.2 Bayer Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Bayer SWOT Analysis
2.4.4 Bayer Product and Services
2.4.5 Bayer Radiopharmaceuticals for Diagnostic Revenue, Gross Margin and Market Share (2018-2019)
2.5 GE Healthcare
2.5.1 GE Healthcare Details
2.5.2 GE Healthcare Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 GE Healthcare SWOT Analysis
2.5.4 GE Healthcare Product and Services
2.5.5 GE Healthcare Radiopharmaceuticals for Diagnostic Revenue, Gross Margin and Market Share (2018-2019)
2.6 Curium Pharmaceuticals
2.6.1 Curium Pharmaceuticals Details
2.6.2 Curium Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Curium Pharmaceuticals SWOT Analysis
2.6.4 Curium Pharmaceuticals Product and Services
2.6.5 Curium Pharmaceuticals Radiopharmaceuticals for Diagnostic Revenue, Gross Margin and Market Share (2018-2019)
2.7 Eli Lilly
2.7.1 Eli Lilly Details
2.7.2 Eli Lilly Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Eli Lilly SWOT Analysis
2.7.4 Eli Lilly Product and Services
2.7.5 Eli Lilly Radiopharmaceuticals for Diagnostic Revenue, Gross Margin and Market Share (2018-2019)
2.8 Lantheus
2.8.1 Lantheus Details
2.8.2 Lantheus Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Lantheus SWOT Analysis
2.8.4 Lantheus Product and Services
2.8.5 Lantheus Radiopharmaceuticals for Diagnostic Revenue, Gross Margin and Market Share (2018-2019)
2.9 Triad Isotopes
2.9.1 Triad Isotopes Details
2.9.2 Triad Isotopes Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Triad Isotopes SWOT Analysis
2.9.4 Triad Isotopes Product and Services
2.9.5 Triad Isotopes Radiopharmaceuticals for Diagnostic Revenue, Gross Margin and Market Share (2018-2019)
2.10 Jubilant Pharma
2.10.1 Jubilant Pharma Details
2.10.2 Jubilant Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Jubilant Pharma SWOT Analysis
2.10.4 Jubilant Pharma Product and Services
2.10.5 Jubilant Pharma Radiopharmaceuticals for Diagnostic Revenue, Gross Margin and Market Share (2018-2019)
2.11 Novartis
2.11.1 Novartis Details
2.11.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Novartis SWOT Analysis
2.11.4 Novartis Product and Services
2.11.5 Novartis Radiopharmaceuticals for Diagnostic Revenue, Gross Margin and Market Share (2018-2019)
2.12 Navidea
2.12.1 Navidea Details
2.12.2 Navidea Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Navidea SWOT Analysis
2.12.4 Navidea Product and Services
2.12.5 Navidea Radiopharmaceuticals for Diagnostic Revenue, Gross Margin and Market Share (2018-2019)
2.13 SIEMENS
2.13.1 SIEMENS Details
2.13.2 SIEMENS Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 SIEMENS SWOT Analysis
2.13.4 SIEMENS Product and Services
2.13.5 SIEMENS Radiopharmaceuticals for Diagnostic Revenue, Gross Margin and Market Share (2018-2019)
2.14 Dongcheng
2.14.1 Dongcheng Details
2.14.2 Dongcheng Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Dongcheng SWOT Analysis
2.14.4 Dongcheng Product and Services
2.14.5 Dongcheng Radiopharmaceuticals for Diagnostic Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Radiopharmaceuticals for Diagnostic Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Radiopharmaceuticals for Diagnostic Players Market Share
3.2.2 Top 10 Radiopharmaceuticals for Diagnostic Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Radiopharmaceuticals for Diagnostic Revenue and Market Share by Regions
4.2 North America Radiopharmaceuticals for Diagnostic Revenue and Growth Rate (2015-2020)
4.3 Europe Radiopharmaceuticals for Diagnostic Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Radiopharmaceuticals for Diagnostic Revenue and Growth Rate (2015-2020)
4.5 South America Radiopharmaceuticals for Diagnostic Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Radiopharmaceuticals for Diagnostic Revenue and Growth Rate (2015-2020)
5 North America Radiopharmaceuticals for Diagnostic Revenue by Countries
5.1 North America Radiopharmaceuticals for Diagnostic Revenue by Countries (2015-2020)
5.2 USA Radiopharmaceuticals for Diagnostic Revenue and Growth Rate (2015-2020)
5.3 Canada Radiopharmaceuticals for Diagnostic Revenue and Growth Rate (2015-2020)
5.4 Mexico Radiopharmaceuticals for Diagnostic Revenue and Growth Rate (2015-2020)
6 Europe Radiopharmaceuticals for Diagnostic Revenue by Countries
6.1 Europe Radiopharmaceuticals for Diagnostic Revenue by Countries (2015-2020)
6.2 Germany Radiopharmaceuticals for Diagnostic Revenue and Growth Rate (2015-2020)
6.3 UK Radiopharmaceuticals for Diagnostic Revenue and Growth Rate (2015-2020)
6.4 France Radiopharmaceuticals for Diagnostic Revenue and Growth Rate (2015-2020)
6.5 Russia Radiopharmaceuticals for Diagnostic Revenue and Growth Rate (2015-2020)
6.6 Italy Radiopharmaceuticals for Diagnostic Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Radiopharmaceuticals for Diagnostic Revenue by Countries
7.1 Asia-Pacific Radiopharmaceuticals for Diagnostic Revenue by Countries (2015-2020)
7.2 China Radiopharmaceuticals for Diagnostic Revenue and Growth Rate (2015-2020)
7.3 Japan Radiopharmaceuticals for Diagnostic Revenue and Growth Rate (2015-2020)
7.4 Korea Radiopharmaceuticals for Diagnostic Revenue and Growth Rate (2015-2020)
7.5 India Radiopharmaceuticals for Diagnostic Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Radiopharmaceuticals for Diagnostic Revenue and Growth Rate (2015-2020)
8 South America Radiopharmaceuticals for Diagnostic Revenue by Countries
8.1 South America Radiopharmaceuticals for Diagnostic Revenue by Countries (2015-2020)
8.2 Brazil Radiopharmaceuticals for Diagnostic Revenue and Growth Rate (2015-2020)
8.3 Argentina Radiopharmaceuticals for Diagnostic Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Radiopharmaceuticals for Diagnostic by Countries
9.1 Middle East & Africa Radiopharmaceuticals for Diagnostic Revenue by Countries (2015-2020)
9.2 Saudi Arabia Radiopharmaceuticals for Diagnostic Revenue and Growth Rate (2015-2020)
9.3 UAE Radiopharmaceuticals for Diagnostic Revenue and Growth Rate (2015-2020)
9.4 Egypt Radiopharmaceuticals for Diagnostic Revenue and Growth Rate (2015-2020)
9.5 South Africa Radiopharmaceuticals for Diagnostic Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Radiopharmaceuticals for Diagnostic Revenue and Market Share by Type (2015-2020)
10.2 Global Radiopharmaceuticals for Diagnostic Market Forecast by Type (2019-2024)
10.3 Tc-99m Revenue Growth Rate (2015-2025)
10.4 F-18 Revenue Growth Rate (2015-2025)
10.5 Other Revenue Growth Rate (2015-2025)
11 Global Radiopharmaceuticals for Diagnostic Market Segment by Application
11.1 Global Radiopharmaceuticals for Diagnostic Revenue Market Share by Application (2015-2020)
11.2 Radiopharmaceuticals for Diagnostic Market Forecast by Application (2019-2024)
11.3 Oncology Revenue Growth (2015-2020)
11.4 Cardiology Revenue Growth (2015-2020)
11.5 Other Revenue Growth (2015-2020)
12 Global Radiopharmaceuticals for Diagnostic Market Size Forecast (2021-2025)
12.1 Global Radiopharmaceuticals for Diagnostic Market Size Forecast (2021-2025)
12.2 Global Radiopharmaceuticals for Diagnostic Market Forecast by Regions (2021-2025)
12.3 North America Radiopharmaceuticals for Diagnostic Revenue Market Forecast (2021-2025)
12.4 Europe Radiopharmaceuticals for Diagnostic Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Radiopharmaceuticals for Diagnostic Revenue Market Forecast (2021-2025)
12.6 South America Radiopharmaceuticals for Diagnostic Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Radiopharmaceuticals for Diagnostic Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Radiopharmaceuticals for Diagnostic Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Radiopharmaceuticals for Diagnostic by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Radiopharmaceuticals for Diagnostic Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Radiopharmaceuticals for Diagnostic Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Bracco Imaging Corporate Information, Location and Competitors
Table 6. Bracco Imaging Radiopharmaceuticals for Diagnostic Major Business
Table 7. Bracco Imaging Radiopharmaceuticals for Diagnostic Total Revenue (USD Million) (2017-2018)
Table 8. Bracco Imaging SWOT Analysis
Table 9. Bracco Imaging Radiopharmaceuticals for Diagnostic Product and Solutions
Table 10. Bracco Imaging Radiopharmaceuticals for Diagnostic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. China Isotope & Radiation Corporate Information, Location and Competitors
Table 12. China Isotope & Radiation Radiopharmaceuticals for Diagnostic Major Business
Table 13. China Isotope & Radiation Radiopharmaceuticals for Diagnostic Total Revenue (USD Million) (2018-2019)
Table 14. China Isotope & Radiation SWOT Analysis
Table 15. China Isotope & Radiation Radiopharmaceuticals for Diagnostic Product and Solutions
Table 16. China Isotope & Radiation Radiopharmaceuticals for Diagnostic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Nordion Corporate Information, Location and Competitors
Table 18. Nordion Radiopharmaceuticals for Diagnostic Major Business
Table 19. Nordion Radiopharmaceuticals for Diagnostic Total Revenue (USD Million) (2017-2018)
Table 20. Nordion SWOT Analysis
Table 21. Nordion Radiopharmaceuticals for Diagnostic Product and Solutions
Table 22. Nordion Radiopharmaceuticals for Diagnostic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Bayer Corporate Information, Location and Competitors
Table 24. Bayer Radiopharmaceuticals for Diagnostic Major Business
Table 25. Bayer Radiopharmaceuticals for Diagnostic Total Revenue (USD Million) (2017-2018)
Table 26. Bayer SWOT Analysis
Table 27. Bayer Radiopharmaceuticals for Diagnostic Product and Solutions
Table 28. Bayer Radiopharmaceuticals for Diagnostic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. GE Healthcare Corporate Information, Location and Competitors
Table 30. GE Healthcare Radiopharmaceuticals for Diagnostic Major Business
Table 31. GE Healthcare Radiopharmaceuticals for Diagnostic Total Revenue (USD Million) (2017-2018)
Table 32. GE Healthcare SWOT Analysis
Table 33. GE Healthcare Radiopharmaceuticals for Diagnostic Product and Solutions
Table 34. GE Healthcare Radiopharmaceuticals for Diagnostic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Curium Pharmaceuticals Corporate Information, Location and Competitors
Table 36. Curium Pharmaceuticals Radiopharmaceuticals for Diagnostic Major Business
Table 37. Curium Pharmaceuticals Radiopharmaceuticals for Diagnostic Total Revenue (USD Million) (2017-2018)
Table 38. Curium Pharmaceuticals SWOT Analysis
Table 39. Curium Pharmaceuticals Radiopharmaceuticals for Diagnostic Product and Solutions
Table 40. Curium Pharmaceuticals Radiopharmaceuticals for Diagnostic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Eli Lilly Corporate Information, Location and Competitors
Table 42. Eli Lilly Radiopharmaceuticals for Diagnostic Major Business
Table 43. Eli Lilly Radiopharmaceuticals for Diagnostic Total Revenue (USD Million) (2017-2018)
Table 44. Eli Lilly SWOT Analysis
Table 45. Eli Lilly Radiopharmaceuticals for Diagnostic Product and Solutions
Table 46. Eli Lilly Radiopharmaceuticals for Diagnostic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Lantheus Corporate Information, Location and Competitors
Table 48. Lantheus Radiopharmaceuticals for Diagnostic Major Business
Table 49. Lantheus Radiopharmaceuticals for Diagnostic Total Revenue (USD Million) (2017-2018)
Table 50. Lantheus SWOT Analysis
Table 51. Lantheus Radiopharmaceuticals for Diagnostic Product and Solutions
Table 52. Lantheus Radiopharmaceuticals for Diagnostic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Triad Isotopes Corporate Information, Location and Competitors
Table 54. Triad Isotopes Radiopharmaceuticals for Diagnostic Major Business
Table 55. Triad Isotopes Radiopharmaceuticals for Diagnostic Total Revenue (USD Million) (2017-2018)
Table 56. Triad Isotopes SWOT Analysis
Table 57. Triad Isotopes Radiopharmaceuticals for Diagnostic Product and Solutions
Table 58. Triad Isotopes Radiopharmaceuticals for Diagnostic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Jubilant Pharma Corporate Information, Location and Competitors
Table 60. Jubilant Pharma Radiopharmaceuticals for Diagnostic Major Business
Table 61. Jubilant Pharma Radiopharmaceuticals for Diagnostic Total Revenue (USD Million) (2017-2018)
Table 62. Jubilant Pharma SWOT Analysis
Table 63. Jubilant Pharma Radiopharmaceuticals for Diagnostic Product and Solutions
Table 64. Jubilant Pharma Radiopharmaceuticals for Diagnostic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Novartis Corporate Information, Location and Competitors
Table 66. Novartis Radiopharmaceuticals for Diagnostic Major Business
Table 67. Novartis Radiopharmaceuticals for Diagnostic Total Revenue (USD Million) (2017-2018)
Table 68. Novartis SWOT Analysis
Table 69. Novartis Radiopharmaceuticals for Diagnostic Product and Solutions
Table 70. Novartis Radiopharmaceuticals for Diagnostic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. Navidea Corporate Information, Location and Competitors
Table 72. Navidea Radiopharmaceuticals for Diagnostic Major Business
Table 73. Navidea Radiopharmaceuticals for Diagnostic Total Revenue (USD Million) (2017-2018)
Table 74. Navidea SWOT Analysis
Table 75. Navidea Radiopharmaceuticals for Diagnostic Product and Solutions
Table 76. Navidea Radiopharmaceuticals for Diagnostic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 77. SIEMENS Corporate Information, Location and Competitors
Table 78. SIEMENS Radiopharmaceuticals for Diagnostic Major Business
Table 79. SIEMENS Radiopharmaceuticals for Diagnostic Total Revenue (USD Million) (2017-2018)
Table 80. SIEMENS SWOT Analysis
Table 81. SIEMENS Radiopharmaceuticals for Diagnostic Product and Solutions
Table 82. SIEMENS Radiopharmaceuticals for Diagnostic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 83. Dongcheng Corporate Information, Location and Competitors
Table 84. Dongcheng Radiopharmaceuticals for Diagnostic Major Business
Table 85. Dongcheng Radiopharmaceuticals for Diagnostic Total Revenue (USD Million) (2017-2018)
Table 86. Dongcheng SWOT Analysis
Table 87. Dongcheng Radiopharmaceuticals for Diagnostic Product and Solutions
Table 88. Dongcheng Radiopharmaceuticals for Diagnostic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 89. Global Radiopharmaceuticals for Diagnostic Revenue (Million USD) by Players (2015-2020)
Table 90. Global Radiopharmaceuticals for Diagnostic Revenue Share by Players (2015-2020)
Table 91. Global Radiopharmaceuticals for Diagnostic Revenue (Million USD) by Regions (2015-2020)
Table 92. Global Radiopharmaceuticals for Diagnostic Revenue Market Share by Regions (2015-2020)
Table 93. North America Radiopharmaceuticals for Diagnostic Revenue by Countries (2015-2020)
Table 94. North America Radiopharmaceuticals for Diagnostic Revenue Market Share by Countries (2015-2020)
Table 95. Europe Radiopharmaceuticals for Diagnostic Revenue (Million USD) by Countries (2015-2020)
Table 96. Asia-Pacific Radiopharmaceuticals for Diagnostic Revenue (Million USD) by Countries (2015-2020)
Table 97. South America Radiopharmaceuticals for Diagnostic Revenue by Countries (2015-2020)
Table 98. South America Radiopharmaceuticals for Diagnostic Revenue Market Share by Countries (2015-2020)
Table 99. Middle East and Africa Radiopharmaceuticals for Diagnostic Revenue (Million USD) by Countries (2015-2020)
Table 100. Middle East and Africa Radiopharmaceuticals for Diagnostic Revenue Market Share by Countries (2015-2020)
Table 101. Global Radiopharmaceuticals for Diagnostic Revenue (Million USD) by Type (2015-2020)
Table 102. Global Radiopharmaceuticals for Diagnostic Revenue Share by Type (2015-2020)
Table 103. Global Radiopharmaceuticals for Diagnostic Revenue Forecast by Type (2021-2025)
Table 104. Global Radiopharmaceuticals for Diagnostic Revenue by Application (2015-2020)
Table 105. Global Radiopharmaceuticals for Diagnostic Revenue Share by Application (2015-2020)
Table 106. Global Radiopharmaceuticals for Diagnostic Revenue Forecast by Application (2021-2025)
Table 107. Global Radiopharmaceuticals for Diagnostic Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Radiopharmaceuticals for Diagnostic Picture
Figure 2. Global Radiopharmaceuticals for Diagnostic Revenue Market Share by Type in 2019
Figure 3. Tc-99m Picture
Figure 4. F-18 Picture
Figure 5. Other Picture
Figure 6. Radiopharmaceuticals for Diagnostic Revenue Market Share by Application in 2019
Figure 7. Oncology Picture
Figure 8. Cardiology Picture
Figure 9. Other Picture
Figure 10. Global Radiopharmaceuticals for Diagnostic Revenue (USD Million) and Growth Rate (2015-2025)
Figure 11. North America Radiopharmaceuticals for Diagnostic Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Europe Radiopharmaceuticals for Diagnostic Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Asia-Pacific Radiopharmaceuticals for Diagnostic Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. South America Radiopharmaceuticals for Diagnostic Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Middle East and Africa Radiopharmaceuticals for Diagnostic Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Radiopharmaceuticals for Diagnostic Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Radiopharmaceuticals for Diagnostic Revenue Share by Players in 2019
Figure 18. Global Top 5 Players Radiopharmaceuticals for Diagnostic Revenue Market Share in 2019
Figure 19. Global Top 10 Players Radiopharmaceuticals for Diagnostic Revenue Market Share in 2019
Figure 20. Key Players Market Share Trend
Figure 21. Global Radiopharmaceuticals for Diagnostic Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 22. Global Radiopharmaceuticals for Diagnostic Revenue Market Share by Regions (2015-2020)
Figure 23. Global Radiopharmaceuticals for Diagnostic Revenue Market Share by Regions in 2018
Figure 24. North America Radiopharmaceuticals for Diagnostic Revenue and Growth Rate (2015-2020)
Figure 25. Europe Radiopharmaceuticals for Diagnostic Revenue and Growth Rate (2015-2020)
Figure 26. Asia-Pacific Radiopharmaceuticals for Diagnostic Revenue and Growth Rate (2015-2020)
Figure 27. South America Radiopharmaceuticals for Diagnostic Revenue and Growth Rate (2015-2020)
Figure 28. Middle East and Africa Radiopharmaceuticals for Diagnostic Revenue and Growth Rate (2015-2020)
Figure 29. North America Radiopharmaceuticals for Diagnostic Revenue Market Share by Countries (2015-2020)
Figure 30. North America Radiopharmaceuticals for Diagnostic Revenue Market Share by Countries in 2019
Figure 31. USA Radiopharmaceuticals for Diagnostic Revenue and Growth Rate (2015-2020)
Figure 32. Canada Radiopharmaceuticals for Diagnostic Revenue and Growth Rate (2015-2020)
Figure 33. Mexico Radiopharmaceuticals for Diagnostic Revenue and Growth Rate (2015-2020)
Figure 34. Europe Radiopharmaceuticals for Diagnostic Revenue Market Share by Countries (2015-2020)
Figure 35. Europe Radiopharmaceuticals for Diagnostic Revenue Market Share by Countries in 2019
Figure 36. Germany Radiopharmaceuticals for Diagnostic Revenue and Growth Rate (2015-2020)
Figure 37. UK Radiopharmaceuticals for Diagnostic Revenue and Growth Rate (2015-2020)
Figure 38. France Radiopharmaceuticals for Diagnostic Revenue and Growth Rate (2015-2020)
Figure 39. Russia Radiopharmaceuticals for Diagnostic Revenue and Growth Rate (2015-2020)
Figure 40. Italy Radiopharmaceuticals for Diagnostic Revenue and Growth Rate (2015-2020)
Figure 41. Asia-Pacific Radiopharmaceuticals for Diagnostic Revenue Market Share by Countries (2015-2020)
Figure 42. Asia-Pacific Radiopharmaceuticals for Diagnostic Revenue Market Share by Countries in 2019
Figure 43. China Radiopharmaceuticals for Diagnostic Revenue and Growth Rate (2015-2020)
Figure 44. Japan Radiopharmaceuticals for Diagnostic Revenue and Growth Rate (2015-2020)
Figure 45. Korea Radiopharmaceuticals for Diagnostic Revenue and Growth Rate (2015-2020)
Figure 46. India Radiopharmaceuticals for Diagnostic Revenue and Growth Rate (2015-2020)
Figure 47. Southeast Asia Radiopharmaceuticals for Diagnostic Revenue and Growth Rate (2015-2020)
Figure 48. South America Radiopharmaceuticals for Diagnostic Revenue Market Share by Countries (2015-2020)
Figure 49. South America Radiopharmaceuticals for Diagnostic Revenue Market Share by Countries in 2019
Figure 50. Brazil Radiopharmaceuticals for Diagnostic Revenue and Growth Rate (2015-2020)
Figure 51. Argentina Radiopharmaceuticals for Diagnostic Revenue and Growth Rate (2015-2020)
Figure 52. Middle East and Africa Radiopharmaceuticals for Diagnostic Revenue Market Share by Countries (2015-2020)
Figure 53. Middle East and Africa Radiopharmaceuticals for Diagnostic Revenue Market Share by Countries in 2019
Figure 54. Saudi Arabia Radiopharmaceuticals for Diagnostic Revenue and Growth Rate (2015-2020)
Figure 55. UAE Radiopharmaceuticals for Diagnostic Revenue and Growth Rate (2015-2020)
Figure 56. Egypt Radiopharmaceuticals for Diagnostic Revenue and Growth Rate (2015-2020)
Figure 57. South Africa Radiopharmaceuticals for Diagnostic Revenue and Growth Rate (2015-2020)
Figure 58. Global Radiopharmaceuticals for Diagnostic Revenue Share by Type (2015-2020)
Figure 59. Global Radiopharmaceuticals for Diagnostic Revenue Share by Type in 2019
Figure 60. Global Radiopharmaceuticals for Diagnostic Market Share Forecast by Type (2021-2025)
Figure 61. Global Tc-99m Revenue Growth Rate (2015-2020)
Figure 62. Global F-18 Revenue Growth Rate (2015-2020)
Figure 63. Global Other Revenue Growth Rate (2015-2020)
Figure 64. Global Radiopharmaceuticals for Diagnostic Revenue Share by Application (2015-2020)
Figure 65. Global Radiopharmaceuticals for Diagnostic Revenue Share by Application in 2019
Figure 66. Global Radiopharmaceuticals for Diagnostic Market Share Forecast by Application (2021-2025)
Figure 67. Global Oncology Revenue Growth Rate (2015-2020)
Figure 68. Global Cardiology Revenue Growth Rate (2015-2020)
Figure 69. Global Other Revenue Growth Rate (2015-2020)
Figure 70. Global Radiopharmaceuticals for Diagnostic Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 71. Global Radiopharmaceuticals for Diagnostic Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 72. Global Radiopharmaceuticals for Diagnostic Revenue Market Share Forecast by Regions (2021-2025)
Figure 73. North America Radiopharmaceuticals for Diagnostic Revenue Market Forecast (2021-2025)
Figure 74. Europe Radiopharmaceuticals for Diagnostic Revenue Market Forecast (2021-2025)
Figure 75. Asia-Pacific Radiopharmaceuticals for Diagnostic Revenue Market Forecast (2021-2025)
Figure 76. South America Radiopharmaceuticals for Diagnostic Revenue Market Forecast (2021-2025)
Figure 77. Middle East and Africa Radiopharmaceuticals for Diagnostic Revenue Market Forecast (2021-2025)
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
診断用放射性医薬品の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The Diagnostic Radiopharmaceuticals market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain opt…- 治療用放射性医薬品の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Radiopharmaceuticals for Therapeutic market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Radiopha…
- アルツハイマー病診断の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Alzheimer's Disease Diagnostic market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Alzheimer's Di…
- カートリッジ式フィールド診断システムの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The Diagnostic Cartridge Field Diagnostic System market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, va…
- ペット用診断検査の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The Pets Diagnostic Tests market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization,…